The EEG system developer raised the series B funding from investors including UCB and LivaNova and will use it commercialise its lead device.

Founded out of Université catholique de Louvain and Wageningen University research, A-Mansia Biotech hopes to commercialise nutritional supplements for patients at heightened cardio-metabolic risk.

The adtech developer has added more than $29m to the $199m it raised in a SenseTime and SBCVC-backed round last month.

Sales enablement platform Highspot has closed a series C round led by Salesforce Ventures, bringing its overall funding to $64m.

The software-testing automation technology developer took its total funding to $30m with a GV-led series B round.

DSM Venturing co-led a $22.5m round for Miach Orthopaedics, which is developing an implant to treat ACL injuries.

The marketing data software provider increased its overall funding to $50m in a series B round featuring returning investor Telstra Ventures.

Zalando and Children’s Investment Fund Foundation have added $2.5m to Working Capital's supply chain-focused fund, which now stands at $25.2m.

Immune-Onc, an immuno-oncology therapy developer exploiting University of Texas research, has received more than $33m from investors including Stanford-StartX fund.

Qualcomm Ventures co-led the series E round, which increased the AR and computer vision technology developer's overall funding to $137m.